Join Rathna Veeramachaneni, Director of Biopharma LC–MS/MS at @KCASBio, as she discusses advanced analytical assays for the bioanalysis of oligonucleotides. Plus, you’ll be able to ask Rathna any questions you have in the live Q&A! Register for the #webinar, in partnership with

#Automation now plays a huge part in laboratory processes. Learn how Worldwide Clinical’ large molecule laboratory is using it to their advantage in this new video interview, available now >>> hubs.ly/Q03vVxCn0

IQVIA Laboratories leads with science From LC–MS/MS to immunoassays, discover cutting-edge lab capabilities in the IQVIA Laboratories company profile on Bioanalysis Zone. Learn more >>> hubs.ly/Q03y1YzJ0

[INFOGRAPHIC] Addressing quality standards for plasmid DNA! This infographic explores how commercial standards and analytical guidelines are shaping the future of plasmid-based therapies. From quality control challenges to practical solutions, discover the benchmarks driving

It’s not too late to watch our latest #PanelDiscussion in partnership with Alturas Analytics, QPS and WuXi AppTec. Watch ‘Advancing bioanalytical method development and validation for small molecules in a changing regulatory landscape’ today! hubs.ly/Q03rQ8t70

2025 Merger & Acquisitions - the first half of the year summarized🤝 The first half of 2025 has brought a wave of mergers and acquisitions that are reshaping the pharma and biotech landscape. From cancer and neuroscience breakthroughs to bioprocessing tools and diagnostics,

Catch up on our latest webinar to gain an insight into solving the #peptide therapeutics puzzle with strategies for smarter development. Watch the #webinar, hosted in partnership with WuXi AppTec, on demand now >>> hubs.ly/Q03tpfQf0

Researchers from The University of Chicago have demonstrated how RNA modification analysis enables highly accurate cancer detection, surpassing traditional DNA methods. Read the full story here >>> hubs.ly/Q03yd3mN0

Teams often encounter challenges when developing #bioanalytical methods for the quantitation of oligonucleotides. Learn strategies on how to overcome these challenges in our upcoming #webinar with SCIEX. Save your seat >>> hubs.ly/Q03wcVMH0

The latest mergers and acquisitions summarized💊 Catch up on the latest deals and activities and what they mean for the bioanalytical industry >>> hubs.ly/Q03yc_kT0

Last chance to register for our webinar, in partnership with SCIEX! Get a masterclass in advanced analytical assays for bioanalysis of #oligonucleotides. Register here >>> hubs.ly/Q03wd3Bn0

While we were at WRIB 2025, we met with the team at Worldwide Clinical to learn all about their large molecule lab and its #automation capabilities. Don’t miss out! Watch the interview >>> hubs.ly/Q03vVyh90

It’s not too late to catch up on our latest #webinar, ‘A masterclass in advanced analytical assays for bioanalysis of oligonucleotides’. Watch here >>> hubs.ly/Q03wc-YV0

Understand key DMPK challenges for peptide therapeutics, including absorption barriers and formulation impact, in our latest #webinar. Watch today! >>> hubs.ly/Q03tpdZX0

The launch of Quanterix's p-Tau 205 and p-Tau 212 assays is advancing Alzheimer’s research by enabling earlier detection and providing deeper insights into disease progression. Learn how these blood-based biomarkers are contributing to advancing neurodegenerative disease

Sava Technologies’ wearable glucose monitor has been granted $19m in Series A funding. Read more about the start-up's device and funding here >>> hubs.ly/Q03C4KCN0

How AI is reshaping compliance with smart bioanalytical validation. In this interview with Srividya Narayanan, we look into the use of AI as a support tool vs. as a decision-maker, as well as the surprising patterns uncovered by AI during bioanalytical validation. Read the full

Missed the AAPS Summer Scientific Forum? No sweat. Read our round-up of the key talks from the Bioanalysis and Pharmaceutical Analysis tracks, written by AAPS leaders >>> hubs.ly/Q03D8zpg0

The University of Arizona has been granted a US$3.8 million grant to determine whether low levels of a lung protein called CC16 could serve as an early indicator of chronic obstructive pulmonary disease, decades before symptoms appear. hubs.ly/Q03DRwrW0

Get your free #poster ‘Development of a highly sensitive ADCC iLite® Reporter Gene Assay’ now. Download now from the @SVARLifeScience’s company profile >>> hubs.ly/Q03BjHCC0